SAGT: 124% | Sagtec Global CEO's 1.5M Share Acquisition And $1.56M Private Placement Coincide With FY2026 Guidance Of 35% Revenue Growth To $25.78M

 

RGNX: 32% | 'FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says' - WSJ

 

GETY: 204% | Reported Sunday, OpenAI And Getty Images Sign Display Agreement To Integrate Licensed Visual Content Into ChatGPT